[1] BERTON-RIGAUD D, DEVOUASSOUX-SHISHEBORAN M, LEDERMANN J A, et al. Gynecologic Cancer InterGroup (GCIG) consensus review for uterine and ovarian carcinosarcoma[J]. Int J Gynecol Cancer, 2014, 24(9 Suppl 3):55-60.
[2] 宋光耀,王亚萍,李广慧, 等.卵巢交界性浆黏液性肿瘤的临床病理学特征[J].中国医师进修杂志,2019,42(1):10-13.
[3] 董燕燕,刘云霄,屈重霄.卵巢交界性浆黏液性肿瘤临床病理特征分析[J].肿瘤研究与临床,2018,30(9):603-606.
[4] CHEN R F, LI J, ZHU T T, et al. Fertility-sparing surgery for young patients with borderline ovarian tumors (BOTs): single institution experience [J]. J Ovarian Res, 2016, 9:16.
[5] LIAN C, CHEN X, NI Y, et al. Pregnancy after fertility-sparing surgery for borderline ovarian tumors[J]. Int J Gynaecol Obstet, 2016, 134(3):282-285.
[6] MORO F, ZANNONI G F, ARCIUOLO D, et al. Imaging in gynecological disease (11): clinical and ultrasound features of mucinous ovarian tumors [J]. Ultrasound Obstet Gynecol, 2017, 50(2):261-270.
[7] 李爽,史小荣,成思荣, 等.BOT的诊疗现状[J].国际妇产科学杂志,2017,44(1):18-22.
[8] 廖薇.卵巢交界性浆黏液性肿瘤临床病理特征分析[J].健康大视野,2019,(24):100.
[9] 王勇.BOT临床病理特征及预后影响因素分析[J].中国医药导报,2017,13(21):123-126.
[10] KIM J Y, NA K, KIM H S. Clinicopathological characteristics of mitotically-active cellular fibroma of the ovary: a single-institutional experience[J]. Anticancer Res, 2017, 37(5):2557-2564.
[11] 钟萍萍,朱力,张立红, 等.卵巢Brenner肿瘤的临床病理分析[J].中华病理学杂志,2019,48(8):615-619.
[12] 石琴,卢晓娟.子宫内膜癌的ADC值与肌层浸润深度的相关性研究[J].中国中西医结合影像学杂志,2020,18(1):68-71.
[13] 林琳,齐铮琴,赵锦, 等.经阴道彩色多普勒超声与病理微血管密度对卵巢肿瘤诊断的相关性研究[J].河北医科大学学报,2019,32(2):158-161. |
